Phase 2 GC/GEJC Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial
GC/GEJC
The First Affiliated Hospital with Nanjing Medical University124 enrolled1 locationNCT07474324
Recruiting
Phase 2
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital25 enrolled1 locationNCT06506292